MANHATTAN, Kan., Nov. 21, 2019 /PRNewswire/ -- Libella Gene Therapeutics, LLC ("Libella") announces an institutional review board (IRB)-approved pay-to-play clinical trial in Colombia (South America) using gene therapy that aims to treat and ultimately cure aging. This could lead to Libella offering the world's only treatment to cure and reverse aging by 20 years.
We and selected third parties collect personal information and use cookies or similar technologies for technical purposes and, with your consent, for functionality, experience, measurement and “marketing (personalized ads)”.
With respect to advertising, we and 904 selected , may use precise geolocation data, and identification through device scanning in order to store and/or access information on a device and process personal data like your usage data for the following : personalised advertising and content, advertising and content measurement, audience research and services development.
You can freely give, deny, or withdraw your consent at any time by accessing the preferences panel. If you give consent, it will be valid only in this domain. Denying consent may make related features unavailable.
Use the “Accept” button to consent. Use the “Reject” button or close this notice to continue without accepting.
